Overview

A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility

Status:
Unknown status
Trial end date:
2019-03-31
Target enrollment:
Participant gender:
Summary
The present investigation is evaluating a method for improving pregnancy outcome of couples with unexplained infertility. The method utilizes an adjuvant pre-treatment prior to insemination, that is pertubation, i.e. flushing the uterus and fallopian tubes before insemination with a specially developed solution with the aim to increase fertility. The clinical trial is a phase II double blind, randomized, controlled and multi-center trial .
Phase:
Phase 2
Details
Lead Sponsor:
Isifer AB
Collaborators:
Ferring Pharmaceuticals
Vinnova